CIK 0001601485 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113430072
- Phone
- (857) 209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-22 | Chudnovsky Yekaterina Director | Purchase | +1,213,000 | $5.81 | $7.0M | 1,915,639 |
| 2022-05-25 | Venkatesan Jay See Remarks | Purchase | +11,313 | $1.25 | $14K | 1,891,947 |
| 2022-05-24 | Venkatesan Jay See Remarks | Purchase | +32,200 | $1.24 | $40K | 1,721,457 |
| 2022-05-20 | Venkatesan Jay See Remarks | Purchase | +50,000 | $1.23 | $62K | 1,689,257 |
| 2022-05-20 | Nissenson Allen Director | Purchase | +2,037 | $1.18 | $2K | 9,383 |
| 2022-05-19 | Nissenson Allen Director | Purchase | +7,346 | $1.16 | $9K | 7,346 |
| 2021-12-28 | Venkatesan Jay See Remarks | Purchase | +210,337 | $2.66 | $560K | 1,639,257 |
| 2021-12-27 | Venkatesan Jay See Remarks | Purchase | +66,907 | $2.55 | $171K | 1,428,920 |
| 2021-12-20 | Venkatesan Jay See Remarks | Purchase | +3,527 | $2.54 | $9K | 1,362,013 |
| 2021-12-17 | Venkatesan Jay See Remarks | Purchase | +13,742 | $2.54 | $35K | 1,358,486 |
| 2021-12-16 | Venkatesan Jay See Remarks | Purchase | +27,883 | $2.55 | $71K | 1,344,744 |
| 2021-12-15 | Venkatesan Jay See Remarks | Purchase | +77,604 | $2.41 | $187K | 1,316,861 |
| 2021-12-15 | CURHAN GREGORY S See Remarks | Purchase | +4,000 | $2.37 | $9K | 4,000 |
Page 1 of 1 · 13 trades